Elevai Skincare - ELAB Net earnings per share for the last four quarters

Elevai Labs Inc (ELAB) - corporate logo

Adherence to strict temperature regimes during the transportation of serums guarantees the bioactivity of Elevai Labs Inc. (ELAB) components. The rolling change in earnings per share YoY reflects price action where the 99.90 level serves as a critical mark. Despite marketing expenses that temporarily reduce free cash flow, current sales of premium lines provide the liquidity necessary to advance scientific research.

ELAB: Elevai Skincare Net earnings per share (EPS TTM) 11/23/2025 - 11/17/2026

Elevai Labs Inc - analytical breakdowns and key metrics (ELAB)

- current quotes and average value forecast:
Fundamental valuation:Elevai Labs - ELAB
Flagship merchandise of Elevai Labs

Elevai Labs Inc. (ELAB) business in the premium cosmeceuticals segment depends on consumer disposable income levels and holiday demand. This sensitivity is directly reflected in the earnings per share dynamics. The metric measures the percentage change in EPS over a rolling year, revealing the actual efficiency of capitalization. Investors use this rate to assess the resilience of earnings to market cycles. By analyzing the annual growth of EPS TTM, one can determine the company's growth phase.